ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
S. D. Randeniya, P. J. Taddei, W. D. Newhauser, P. Yepes
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 810-814
MC Calculations | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9310
Articles are hosted by Taylor and Francis Online.
Monte Carlo simulations of an ocular treatment beamline consisting of a nozzle and a water phantom were carried out using MCNPX, GEANT4, and FLUKA to compare the dosimetric accuracy and the simulation efficiency of the codes. Simulated central axis percent depth-dose profiles and cross-field dose profiles were compared with experimentally measured data for the comparison. Simulation speed was evaluated by comparing the number of proton histories simulated per second using each code. The results indicate that all the Monte Carlo transport codes calculate sufficiently accurate proton dose distributions in the eye and that the FLUKA transport code has the highest simulation efficiency.
